Keyphrases
Prophylactic Cranial Irradiation
100%
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
100%
Irradiation
100%
Confidence Interval
83%
Intracranial Metastases
50%
Disease-free Survival
33%
Brain Metastases
33%
Randomized Trial
16%
Low Risk
16%
1-year Survival
16%
Hazard Ratio
16%
Median Overall Survival
16%
Cumulative Risk
16%
Global Health Status
16%
Overall Survival
16%
Baseline Characteristics
16%
Computed Tomography
16%
Therapy Control
16%
Response to Chemotherapy
16%
Well-balancing
16%
Brain Magnetic Resonance Imaging
16%
Clinically Significant
16%
Medicine and Dentistry
Brain Metastasis
100%
Small Cell Lung Cancer
100%
Prophylactic Cranial Irradiation
100%
Disease Free Survival
40%
Overall Survival
40%
Survival Rate
20%
Hazard Ratio
20%
Health Status
20%
Magnetic Resonance Imaging of the Brain
20%
Side Effect
20%
Computer Assisted Tomography
20%
Immunology and Microbiology
Disease Free Survival
100%
Overall Survival
100%
Magnetic Resonance Imaging
50%
Health Status
50%
Computer Assisted Tomography
50%
Survival Rate
50%
Biochemistry, Genetics and Molecular Biology
Disease Free Survival
100%
Overall Survival
100%
Computer Assisted Tomography
50%
Survival Rate
50%
Health Status
50%
Magnetic Resonance Imaging
50%